GLP-1s are not necessary for everyone, though
That may include weight loss, improved insulin sensitivity, reduced visceral fat, better cardiometabolic markers, lower inflammatory burden, improved mobility, and greater capacity to exercise
Tirzepatide Tirzepatide, also known by the brand names Mounjaro and Zepbound, is a GLP-1 agonist like semaglutide, but it works better for most people because it targets both GIP and GLP-1 receptors, leading to more effective weight loss and blood sugar control
Epidemiology Gamma-glutamyl transpeptidase deficiency is a very rare disease, which has been reported in seven patients in five families worldwide [3337]
Semaglutide is a medication often prescribed for managing type 2 diabetes and aiding weight loss